Karuna CEO says he doesn't expect company's KarXT schizophrenia drug to lose its efficacy over time
Share

Karuna CEO says he doesn't expect company's KarXT schizophrenia drug to lose its efficacy over time

CNBC's Jim Cramer spoke with Karuna Therapeutics CEO Steve Paul on Wednesday's episode of "Mad Money."
01:56
Wed, Aug 17 20227:11 PM EDT